EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy

Sondre Meling iD, Erling Tjora iD, Heike Eichele iD, Niels Ejskjaer iD, Siri Carlsen iD, Pål Rasmus Njølstad iD, Christina Brock iD, Eirik Søfteland iD

Journal of Diabetes Research · 09.08.2023 · 2023 · 1-9

DOI: 10.1155/2023/4441115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, erschienen am 09.08.2023. Verfasst von Sondre Meling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stavanger University Hospital, Stavanger, Norway. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Prediabetic State. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest, Haukeland Universitetssjukehus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims. Autonomic neuropathy is a common but often neglected complication of diabetes, prediabetes, and even in individuals with an elevated risk of diabetes. The Composite Autonomic Symptom Score (COMPASS) 31 is a validated and easy-to-use questionnaire regarding autonomic symptoms. We aimed to use a digitally, Norwegian version of the COMPASS 31 in people with different durations of diabetes and healthy controls to consider feasibility and to investigate if scores could discriminate between positive and negative outcomes for established tests for diabetic neuropathy, including cardiovascular autonomic neuropathy (CAN) and a novel method of examining the gastrointestinal visceral sensitivity.

Method

We included 21 participants with longstanding type 2 diabetes, 15 with early type 2 diabetes, and 30 matched controls. The mean age for all groups was 69 years. Participants were phenotyped by cardiovascular autonomic reflex tests, electrical skin conductance, sural nerve electrophysiology, and the monofilament test. As a proxy for gastrointestinal visceral and autonomic nerve function, evoked potentials were measured following rapid rectal balloon distention.

Results

Participants with longstanding diabetes scored a median (IQR) of 14.9 (10.8-28.7) points, early diabetes of 7.3 (1.6-15.2), and matched controls of 8.6 (4.1-21.6), p = 0.04 . Women and men scored 14.4 (5.5-28.7) and 7.8 (3.6-14.6) points, respectively, p = 0.01 . Participants with definite or borderline CAN scored 14.3 (10.4-31.9) points, compared to participants with no CAN, 8.3 (3.2-21.5), p = 0.04 . Lowering the diagnostic cut-off from 16 to 10 points increased the sensitivity from 0.33 to 0.83, with a decreased specificity from 0.68 to 0.55.

Conclusion

We successfully used COMPASS 31 in Norwegian. Thus, following the guidelines, we suggest clinical implementation for the assessment of autonomic neuropathy. Participants with longstanding diabetes had an increased likelihood of symptoms and signs of autonomic neuropathy. For screening purposes, the sensitivity was improved by lowering the cut-off to 10 points, with a lower score nearly excluding the diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NeuropathiesPrediabetic StateAgedFemaleHumansMaleAutonomic Nervous SystemRisk Factors

Autor:innen und Institutionen

  • Department of Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Children and Youth Clinic, Haukeland University Hospital, Bergen, Norway.
  • Department of Biological and Medical Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
  • Regional Resource Centre for Autism, ADHD and Tourette Syndrome Western Norway, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, Faculty of Medicine, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Sondre Meling, Erling Tjora, Heike Eichele, Niels Ejskjaer, Siri Carlsen, Pål Rasmus Njølstad, Christina Brock, Eirik Søfteland

Förderung

  • Helse Vest
  • Haukeland Universitetssjukehus

Zitieren

APA

Meling, S., Tjora, E., Eichele, H., Ejskjaer, N., Carlsen, S., Njølstad, P. R., Brock, C., & Søfteland, E. (2023). The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy. Journal of Diabetes Research, 2023, 1-9. https://doi.org/10.1155/2023/4441115

Vancouver

Meling S, Tjora E, Eichele H, Ejskjaer N, Carlsen S, Njølstad PR, et al. The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy. Journal of Diabetes Research. 2023;2023:1-9. doi:10.1155/2023/4441115

BibTeX
@article{Meling2023,
  author = {Meling, Sondre and Tjora, Erling and Eichele, Heike and Ejskjaer, Niels and Carlsen, Siri and Njølstad, Pål Rasmus and Brock, Christina and Søfteland, Eirik},
  title = {The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy},
  journal = {Journal of Diabetes Research},
  year = {2023},
  volume = {2023},
  pages = {1--9},
  doi = {10.1155/2023/4441115}
}
Kostenlos starten →